Marco Investment Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $241K | Hold |
6,550
| – | – | 0.02% | 210 |
|
|
2025
Q4 | $333K | Hold |
6,550
| – | – | 0.03% | 171 |
|
|
2025
Q3 | $363K | Sell |
6,550
-152
| -2% | -$8.9K | 0.03% | 159 |
|
|
2025
Q2 | $463K | Hold |
6,702
| – | – | 0.04% | 147 |
|
|
2025
Q1 | $465K | Hold |
6,702
| – | – | 0.04% | 149 |
|
|
2024
Q4 | $577K | Hold |
6,702
| – | – | 0.05% | 139 |
|
|
2024
Q3 | $798K | Buy |
6,702
+100
| +2% | +$13.3K | 0.07% | 125 |
|
|
2024
Q2 | $942K | Hold |
6,602
| – | – | 0.09% | 116 |
|
|
2024
Q1 | $848K | Buy |
6,602
+152
| +2% | +$18.1K | 0.08% | 120 |
|
|
2023
Q4 | $667K | Hold |
6,450
| – | – | 0.07% | 129 |
|
|
2023
Q3 | $587K | Hold |
6,450
| – | – | 0.07% | 128 |
|
|
2023
Q2 | $522K | Sell |
6,450
-1,200
| -16% | -$98K | 0.06% | 141 |
|
|
2023
Q1 | $609K | Sell |
7,650
-500
| -6% | -$35.5K | 0.07% | 137 |
|
|
2022
Q4 | $552K | Buy |
8,150
+500
| +7% | +$29.3K | 0.06% | 142 |
|
|
2022
Q3 | $381K | Hold |
7,650
| – | – | 0.05% | 149 |
|
|
2022
Q2 | $426K | Hold |
7,650
| – | – | 0.05% | 150 |
|
|
2022
Q1 | $425K | Sell |
7,650
-64
| -0.8% | -$3.29K | 0.04% | 154 |
|
|
2021
Q4 | $432K | Buy |
7,714
+64
| +0.8% | +$3.47K | 0.04% | 157 |
|
|
2021
Q3 | $367K | Hold |
7,650
| – | – | 0.04% | 166 |
|
|
2021
Q2 | $320K | Hold |
7,650
| – | – | 0.04% | 164 |
|
|
2021
Q1 | $258K | Hold |
7,650
| – | – | 0.03% | 171 |
|
|
2020
Q4 | $267K | Hold |
7,650
| – | – | 0.04% | 165 |
|
|
2020
Q3 | $266K | Hold |
7,650
| – | – | 0.04% | 146 |
|
|
2020
Q2 | $250K | Hold |
7,650
| – | – | 0.05% | 143 |
|
|
2020
Q1 | $230K | Hold |
7,650
| – | – | 0.05% | 147 |
|
|
2019
Q4 | $221K | Buy |
+7,650
| New | +$212K | 0.03% | 167 |
|
|
2019
Q2 | – | Sell |
-7,650
| Closed | -$200K | – | 182 |
|
|
2019
Q1 | $200K | Buy |
+7,650
| New | +$188K | 0.04% | 170 |
|
|
2018
Q1 | – | Sell |
-7,650
| Closed | -$205K | – | 188 |
|
|
2017
Q4 | $205K | Buy |
+7,650
| New | +$195K | 0.03% | 173 |
|
|
2016
Q4 | – | Sell |
-10,084
| Closed | -$210K | – | 187 |
|
|
2016
Q3 | $210K | Hold |
10,084
| – | – | 0.04% | 172 |
|
|
2016
Q2 | $271K | Hold |
10,084
| – | – | 0.05% | 161 |
|
|
2016
Q1 | $273 | Hold |
10,084
| – | – | 0.04% | 166 |
|
|
2015
Q4 | $293K | Hold |
10,084
| – | – | 0.05% | 166 |
|
|
2015
Q3 | $273K | Hold |
10,084
| – | – | 0.05% | 162 |
|
|
2015
Q2 | $276K | Buy |
+10,084
| New | +$283K | 0.05% | 168 |
|
Other funds holding NVO
DAM
F
Marco Investment Management's NVO Position: Q1 2026 in Review
Marco Investment Management held its Novo Nordisk (NVO) position steady in Q1 2026 at 6,550 shares worth $241K. The position accounts for 0.02% of the portfolio, ranked #210.
Marco Investment Management first reported a position in NVO in Q2 2015 and has held it in 34 quarters since. The position peaked at $942K in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Marco Investment Management held 6,550 shares of Novo Nordisk worth $241K as of Q1 2026.
- Marco Investment Management left its Novo Nordisk share count unchanged in Q1 2026.
- Novo Nordisk made up 0.02% of Marco Investment Management's portfolio in Q1 2026, its #210 holding.
- Marco Investment Management first reported a position in Novo Nordisk in Q2 2015 and has held it in 34 quarters since.
- Marco Investment Management's Novo Nordisk position peaked at $942K in Q2 2024.
- 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Marco Investment Management's 13F filing for Q1 2026, filed 8 May 2026.